ConductScience.org, home

Paper68239

Labetalol in hypertension.

Lancet, 1977. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Labetalol in hypertension. Papers, record 68239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Labetalol in hypertension.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Letter
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2015-06-16
PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AntagonistsMajor topic
Antihypertensive AgentsMajor topic
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Adolescent
Drug Evaluation
Female
Humans
Hypotension, Orthostatic
Infusions, Parenteral
Injections, Intravenous

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
7093106Intravenous labetalol in severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093106PubMed
7093105Intravenous labetalol in the treatment of severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093105PubMed
7082539Rapid reduction of blood pressure with acute oral labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7082539PubMed
6124265Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124265PubMed
3530297The management of hypertension.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3530297PubMed
667582Treatment of hypertensive emergencies with oral labetalol.Br Med J1978https://conductscience.org/library/papers/667582PubMed
508511Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/508511PubMed
393288Treatment of severe hypertension by repeated bolus injections of labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/393288PubMed
115540Hemiparesis after single minibolus of labetalol for hypertensive encephalopathy.Br Med J1979https://conductscience.org/library/papers/115540PubMed
26370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68239

GET https://conductscience.org/api/papers/v1/68239/authors